Suppression of receptor-mediated Ca2+ mobilization and functional leukocyte responses by hyperforin
- 15 April 2004
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 67 (8), 1531-1539
- https://doi.org/10.1016/j.bcp.2003.12.020
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Studies on the Antioxidative Activity of Phloroglucinol Derivatives Isolated fromHypericumSpeciesPlanta Medica, 2003
- Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosisOncogene, 2002
- Stimulation of Glutamate, Aspartate and Gamma-Aminobutyric Acid Release from Synaptosomes by HyperforinPharmacopsychiatry, 2001
- Regulation of Phosphoinositide-Specific Phospholipase CAnnual Review of Biochemistry, 2001
- Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human VolunteersPharmacopsychiatry, 1998
- Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.Journal of Clinical Investigation, 1997
- Calcium and signal transduction in granulocytesCurrent Opinion in Hematology, 1996
- A phospholipase C inhibitor, U-73122, blocks TSH-induced inositol trisphosphate production, Ca2+ increase and arachidonic acid release in FRTL-5 thyroid cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Inositol trisphosphate and calcium signallingNature, 1993
- Platelet-activating factor mediated effects on human neutrophil function are inhibited by pertussis toxinBiochemical and Biophysical Research Communications, 1985